Skip to content

Comparative Study of the Effectiveness of Two Different Doses of Intravenous Labetalol on Cardiovascular Response to Tracheal Extubation

Comparative Study of the Effectiveness of Two Different Doses of Intravenous Labetalol on Cardiovascular Response to Tracheal Extubation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180416039326N16
Enrollment
72
Registered
2020-11-30
Start date
2021-01-19
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal Extubation.

Interventions

Intervention 1: Intervention group 1: In this group, a syringe containing labetalol (0.1 mg / kg diluted with 0.9% saline to a volume of 5 ml) will be injected. Intervention 2: Intervention group 2: I

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Normotensive patients who are candidates for elective surgery less than two hours under general anesthesia requiring endotracheal intubation Age between 20 to 60 years ASA one and two Informed consent to participate in the study Weight 55 to 85 kilogram

Exclusion criteria

Exclusion criteria: Pregnant women Diabetic patients Patients with uncontrolled underlying cardiovascular disease Baseline heart rate less than 60 beats per minute and systolic blood pressure less than 90 mmHg Patients with cerebrovascular diseases Contraindication of the use of study medicines Known allergy to anesthetics in the study Opioid abuse Taking medicines with cardiovascular effects

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure. Timepoint: Before extubation and 1, 3, 5 and 10 minutes after extubation. Method of measurement: Barometer.;Diastolic blood pressure. Timepoint: Before extubation and 1, 3, 5 and 10 minutes after extubation. Method of measurement: Barometer.;Pulse rate. Timepoint: Before extubation and 1, 3, 5 and 10 minutes after extubation. Method of measurement: Pulse oximetry.;Oxygen saturation percentage. Timepoint: Before extubation and 1, 3, 5 and 10 minutes after extubation. Method of measurement: Pulse oximetry.;Mean arterial pressure. Timepoint: Before extubation and 1, 3, 5 and 10 minutes after extubation. Method of measurement: Barometer.

Secondary

MeasureTime frame
Duration of staying in recovery. Timepoint: Based on minutes from arrival to reaching the modified aldrete score of 9. Method of measurement: Information collection form.;Adverse airway response. Timepoint: During the time of staying in recovery. Method of measurement: Information collection form.;Hemodynamic complications. Timepoint: During the time of staying in recovery. Method of measurement: Information collection form.;Duration of extubation. Timepoint: Based on minutes from the time of discontinuing anesthetics to the time of extubation. Method of measurement: Information collection form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Shetabi

Esfahan University of Medical Sciences

hamidshetabi@med.mui.ac.ir+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026